Related Experiment Videos
Gene therapy: twenty-first century medicine
Inder M Verma1, Matthew D Weitzman
1Laboratory of Genetics, The Salk Institute, La Jolla, California 92037, USA. verma@salk.edu
Annual Review of Biochemistry
|June 15, 2005
Summary
Gene therapy transfers genetic material to treat diseases. Viral vectors are crucial for efficient gene delivery, but ongoing vector development is essential for improving gene therapy success.
Area of Science:
- Biotechnology
- Molecular Biology
- Medical Science
Background:
- Gene therapy aims to treat diseases by transferring genetic material.
- Efficient and safe gene delivery systems are critical for therapeutic success.
- Viral vectors are currently the most effective means for gene transfer.
Purpose of the Study:
- To review the role of gene delivery systems in gene therapy.
- To discuss the performance and safety of various viral vectors.
- To highlight the importance of vector development for advancing gene therapy.
Main Methods:
- Evaluation of viral vector performance and pathogenicity in animal models.
- Review of existing literature on gene therapy vectors.
- Analysis of data from clinical trials using viral vectors.
Main Results:
- Viral vectors, including retroviruses, lentiviruses, adenoviruses, and adeno-associated viruses, show promise for efficient gene delivery.
- Animal model studies indicate encouraging results for vector safety and efficacy.
- Clinical trials have demonstrated initial success in treating genetic and acquired diseases.
Conclusions:
- Viral vectors are the leading choice for gene therapy delivery systems.
- Continued research and development of vectors are paramount for enhancing gene therapy efficacy and safety.
- Addressing vector-related challenges is key to realizing the full potential of gene therapy.